Are there lasting side effects of taking Keppra (levetiracetam) for three weeks in a two-year-old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lasting Side Effects of Keppra (Levetiracetam) in a Two-Year-Old After Three Weeks of Treatment

Keppra (levetiracetam) taken for three weeks in a two-year-old typically does not cause lasting side effects after discontinuation, as it has a short half-life of approximately 5 hours in children and is generally well-tolerated. 1

Common Side Effects During Treatment

Levetiracetam may cause several side effects while the child is taking the medication, including:

  • Behavioral effects: The most concerning side effects in children are behavioral, including:

    • Irritability
    • Aggression
    • Nervousness
    • Hostility
    • Mood lability 2
  • Neurological effects:

    • Somnolence/drowsiness
    • Fatigue
    • Dizziness 1
  • Less common effects:

    • Nausea
    • Rash 1

Duration of Effects After Discontinuation

According to pharmacokinetic data in pediatric guidelines, levetiracetam has a relatively short elimination half-life in children:

  • In children 4-12 years: 5 hours 1
  • In younger children: Potentially faster clearance due to higher metabolic rates

This suggests that after discontinuation, the drug would be eliminated from the body within 1-2 days (5-6 half-lives), and direct drug effects would cease shortly thereafter.

Risk of Lasting Effects

The evidence indicates that most side effects of levetiracetam are transient and resolve upon discontinuation:

  • Behavioral side effects, while potentially troublesome during treatment, typically resolve completely when the medication is discontinued 3
  • A case report of a 6-year-old who developed autistic regression on levetiracetam showed "dramatic response with complete resolution of new abnormal findings" after the medication was stopped 3

Special Considerations for Two-Year-Olds

For very young children (two years old), special attention should be paid to:

  1. Developmental monitoring: While lasting effects are unlikely, parents should monitor for any changes in developmental milestones or behavior patterns after discontinuation

  2. Seizure monitoring: If Keppra was prescribed for seizure control, parents should be vigilant for seizure recurrence after discontinuation

When to Seek Medical Attention

Parents should contact their healthcare provider if they observe:

  • Any new behavioral changes that persist more than a few days after discontinuation
  • Return of seizures (if applicable)
  • Any unusual symptoms that weren't present before starting the medication

Conclusion

Based on the pharmacokinetic profile and available evidence, levetiracetam taken for a short duration (three weeks) in a two-year-old child is unlikely to cause lasting side effects after discontinuation. The medication is eliminated relatively quickly from the body, and most side effects resolve when the drug is stopped.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.